New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
06:20 EDTDOXAmdocs upgraded to Outperform from Perform at Oppenheimer
Oppenheimer upgraded Amdocs with a $47 price target citing the company's solid Q1 results and slightly improved FY14 guidance. Opco says the stock tends to outperform in uncertain market conditions.
News For DOX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 21, 2015
15:18 EDTDOXAmdocs reported interest in Comverse billing unit makes sense, says JPMorgan
After Israel's Globes said that Amdocs (DOX) is in advanced talks to buy Comverse's (CNSI) billing unit for $300M-$400M, JPMorgan said it believes Comverse has had the unit up for sale for quite some time and that such a deal could make strategic and financial sense for Amdocs. However, the firm added that such a deal might suggest that Amdocs management sees limited opportunities for organic growth in the near-term. JPMorgan has a Neutral rating on Amdocs shares.
15:11 EDTDOXAmdocs in discussions to acquire Comverse billing division, Globes says
Amdocs (DOX) is in discussions to acquire Comverse's (CNSI) billing division for $300M-$400M, according to Globes. Reference Link
06:23 EDTDOXAmdocs price target raised to $62 from $55 at Citigroup
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use